Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP284813.RAv64ngsUBVVf49o_o9LPh_dNQzO5pK3ORxOgZmz6zO_k130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP284813.RAv64ngsUBVVf49o_o9LPh_dNQzO5pK3ORxOgZmz6zO_k130_assertion type Assertion NP284813.RAv64ngsUBVVf49o_o9LPh_dNQzO5pK3ORxOgZmz6zO_k130_head.
- NP284813.RAv64ngsUBVVf49o_o9LPh_dNQzO5pK3ORxOgZmz6zO_k130_assertion description "[In this study, we further characterized the FL3B lymphomas that are currently part of the spectrum of FL in the WHO classification, taking into account other cytogenetical aberrations, immunohistochemistry for P53, bcl2, bcl6, and CD10, rearrangement of the proto-oncogene myc, and mutation of the tumor suppressor gene TP53.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP284813.RAv64ngsUBVVf49o_o9LPh_dNQzO5pK3ORxOgZmz6zO_k130_provenance.
- NP284813.RAv64ngsUBVVf49o_o9LPh_dNQzO5pK3ORxOgZmz6zO_k130_assertion evidence source_evidence_literature NP284813.RAv64ngsUBVVf49o_o9LPh_dNQzO5pK3ORxOgZmz6zO_k130_provenance.
- NP284813.RAv64ngsUBVVf49o_o9LPh_dNQzO5pK3ORxOgZmz6zO_k130_assertion SIO_000772 16647949 NP284813.RAv64ngsUBVVf49o_o9LPh_dNQzO5pK3ORxOgZmz6zO_k130_provenance.
- NP284813.RAv64ngsUBVVf49o_o9LPh_dNQzO5pK3ORxOgZmz6zO_k130_assertion wasDerivedFrom befree-20140225 NP284813.RAv64ngsUBVVf49o_o9LPh_dNQzO5pK3ORxOgZmz6zO_k130_provenance.
- NP284813.RAv64ngsUBVVf49o_o9LPh_dNQzO5pK3ORxOgZmz6zO_k130_assertion wasGeneratedBy ECO_0000203 NP284813.RAv64ngsUBVVf49o_o9LPh_dNQzO5pK3ORxOgZmz6zO_k130_provenance.